At Worldwide, we understand that obesity is a complex condition that demands a nuanced approach in clinical research. Our poster, presented at Obesity Week 2024, examines the multifaceted nature of body composition assessments and their critical role in clinical trial design.
Key highlights include:
- Strategic endpoint selection
- Comparative assessment techniques
- Our study design process
Download our poster to learn more about our tailored approach that integrates scientific, medical, and operational perspectives in managing obesity studies.
Authors:
Alessandra Vignola
President, Cardiovascular & Metabolic
MarieElena Cordisco
Senior Director Therapeutic Strategy Lead Metabolic
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
Peyton Sandroni, PhD Fellow
Clinical Research Methodology, Cardiometabolic
